These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cross-species receptor binding characteristics of human and mouse leukemia inhibitory factor suggest a complex binding interaction. Layton MJ, Lock P, Metcalf D, Nicola NA. J Biol Chem; 1994 Jun 24; 269(25):17048-55. PubMed ID: 8006010 [Abstract] [Full Text] [Related]
3. The unusual species cross-reactivity of the leukemia inhibitory factor receptor alpha-chain is determined primarily by the immunoglobulin-like domain. Owczarek CM, Zhang Y, Layton MJ, Metcalf D, Roberts B, Nicola NA. J Biol Chem; 1997 Sep 19; 272(38):23976-85. PubMed ID: 9295349 [Abstract] [Full Text] [Related]
4. Conversion of the biological specificity of murine to human leukemia inhibitory factor by replacing 6 amino acid residues. Layton MJ, Owczarek CM, Metcalf D, Clark RL, Smith DK, Treutlein HR, Nicola NA. J Biol Chem; 1994 Nov 25; 269(47):29891-6. PubMed ID: 7961984 [Abstract] [Full Text] [Related]
5. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit. Tanaka M, Hara T, Copeland NG, Gilbert DJ, Jenkins NA, Miyajima A. Blood; 1999 Feb 01; 93(3):804-15. PubMed ID: 9920829 [Abstract] [Full Text] [Related]
6. Characterization of the receptor binding sites of human leukemia inhibitory factor and creation of antagonists. Hudson KR, Vernallis AB, Heath JK. J Biol Chem; 1996 May 17; 271(20):11971-8. PubMed ID: 8662595 [Abstract] [Full Text] [Related]
7. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor. Plun-Favreau H, Perret D, Diveu C, Froger J, Chevalier S, Lelièvre E, Gascan H, Chabbert M. J Biol Chem; 2003 Jul 18; 278(29):27169-79. PubMed ID: 12707269 [Abstract] [Full Text] [Related]
8. Inter-species chimeras of leukemia inhibitory factor define a human receptor binding site. Owczarek CM, Layton MJ, Metcalf D, Clark R, Gough NM, Nicola NA. Ann N Y Acad Sci; 1995 Jul 21; 762():165-78. PubMed ID: 7668527 [No Abstract] [Full Text] [Related]
9. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Ichihara M, Hara T, Kim H, Murate T, Miyajima A. Blood; 1997 Jul 01; 90(1):165-73. PubMed ID: 9207450 [Abstract] [Full Text] [Related]
11. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190. Heymann D, Godard A, Raher S, Bentouimou N, Blanchard F, Cherel M, Hallet MM, Jacques Y. Cytokine; 1996 Mar 01; 8(3):197-205. PubMed ID: 8833034 [Abstract] [Full Text] [Related]
14. Complex binding of leukemia inhibitory factor to its membrane-expressed and soluble receptors. Layton MJ, Owczarek CM, Metcalf D, Lock PA, Wilson TA, Gough NM, Hilton DJ, Nicola NA. Proc Soc Exp Biol Med; 1994 Jul 01; 206(3):295-8. PubMed ID: 8016167 [Abstract] [Full Text] [Related]
15. The crystal structure of murine leukemia inhibitory factor. Robinson RC, Grey LM, Staunton D, Stuart DI, Heath JK, Jones EY. Ann N Y Acad Sci; 1995 Jul 21; 762():179-87; discussion 187-8. PubMed ID: 7668528 [Abstract] [Full Text] [Related]
16. Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF. Bitard J, Daburon S, Duplomb L, Blanchard F, Vuisio P, Jacques Y, Godard A, Heath JK, Moreau JF, Taupin JL. J Biol Chem; 2003 May 02; 278(18):16253-61. PubMed ID: 12601009 [Abstract] [Full Text] [Related]